KATP channel mutations in congenital hyperinsulinism

Seminars in Pediatric Surgery

Volumn 20, Issue 1, 2011, Pages 18-22

  Saint Martin, Cécile ^a   Arnoux, Jean Baptiste ^b   de Lonlay, Pascale ^b   Bellanné Chantelot, Christine ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Congenital hyperinsulinism; Diazoxide responsiveness; Hyperinsulinemic hypoglycemia; KATP channel; Kir6.2; SUR1

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DIAZOXIDE; GLUCOSE; GLUCOSE TRANSPORTER 2; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA RECEPTOR 1;

ARTICLE; CELL METABOLISM; CELL PROLIFERATION; DEPOLARIZATION; EXOCYTOSIS; GENE FREQUENCY; GLUCOSE TRANSPORT; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INSULIN RELEASE; LOSS OF FUNCTION MUTATION; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRIORITY JOURNAL; RECESSIVE INHERITANCE;

ATP-BINDING CASSETTE TRANSPORTERS; DIAZOXIDE; HUMANS; KATP CHANNELS; MUTATION; PERSISTENT HYPERINSULINEMIA HYPOGLYCEMIA OF INFANCY; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; VASODILATOR AGENTS;

EID: 78650441173     PISSN: 10558586     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.sempedsurg.2010.10.012     Document Type: Article

References (27)

1. Ashcroft F.M., Harrison D.E., Ashcroft S.J. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 1984, 312:446-448.
2. Tucker S.J., Gribble F.M., Zhao C., et al. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature 1997, 387:179-183.
3. Gribble F.M., Tucker S.J., Haug T., et al. MgATP activates the β-cell KATP channel by interaction with its SUR1 subunit. Proc Natl Acad Sci U S A 1998, 95:7185-7190.
4. Clement J.P., Kunjilwar K., Gonzalez G., et al. Association and stoichiometry of KATP channel subunits. Neuron 1997, 18:827-838.
5. Sakura H., Ammala C., Smith P.A., et al. Cloning and functional expression of the cDNA encoding a novel ATPsensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscle. FEBS Lett 1995, 377:338-344.
6. Aguilar-Bryan L., Nichols C.G., Wechsler S.W., et al. Cloning of the β-cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995, 268:423-426.
7. Flanagan S., Clauin S., Bellanné-Chantelot C., et al. Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 2009, 30:170-180.
8. Ashcroft F.M. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 2005, 115:2047-2058.
9. Rahier J., Fält K., Müntefering H., et al. The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells?. Diabetologia 1984, 26:282-289.
10. de Lonlay P., Fournet J., Rahier J., et al. Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. J Clin Invest 1997, 100:802-807.
11. Verkarre V., Fournet J.C., de Lonlay P., et al. Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. J Clin Invest 1998, 102:1286-1291.
12. Thomas P.M., Cote G.J., Wohllk N., et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995, 268:426-429.
13. Thomas P., Ye Y., Lightner E. Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum Mol Genet 1996, 5:1809-1812.
14. de Lonlay P., Fournet J., Touati G., et al. Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases. Eur J Pediatr 2002, 161:37-48.
15. Bellanné-Chantelot C., Saint-Martin C., Ribeiro M.J., et al. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. J Med Genet 2010, 47:752-759.
16. Sempoux C., Guiot Y., Cosgrove K., et al. A new morphological form of persistent hyperinsulinaemic hypoglycaemia of infancy: correlation with clinical and physiological data. Horm Res 2002, 58(Suppl 2). P1-146).
17. Hussain K., Flanagan S., Smith V., et al. An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism. Diabetes 2008, 57:259-263.
18. Nestorowicz A., Wilson B.A., Schoor K.P., et al. Mutations in the sulphonylurea gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 1996, 5:1813-1822.
19. Otonkoski T., Ammala C., Huopio H., et al. A point mutation inactivating the sulphonlurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland. Diabetes 1999, 48:408-415.
20. Huopio H., Reimann F., Ashfield R., et al. Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest 2000, 106:897-906.
21. Suchi M., MacMullen C., Thornton P., et al. Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism. Mod Pathol 2006, 19:122-129.
22. Nestorowicz A., Glaser B., Wilson B., et al. Genetic heterogeneity in familial hyperinsulinism. Hum Mol Genet 1998, 7:1119-1128.
23. Fernández-Marmiesse A., Salas A., Vega A., et al. Mutation spectra of ABCC8 gene in Spanish patients with hyperinsulinism of infancy (HI). Hum Mutat 2006, 27:214.
24. Flanagan S.E., Kapoor R.R., Mali G., et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol 2010, 162:987-992.
25. Thornton P.S., MacMullen C., Ganguly A., et al. Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor. Diabetes 2003, 52:2403-2410.
26. Pinney S., MacMullen C., Becker S., et al. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. J Clin Invest 2008, 118:2877-2886.
27. Huopio H., Otonkoski T., Vauhkonen I., et al. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for the sulphonlyurea receptor. 1. Lancet 2003, 361:301-307.